MiMedx Group Provides Update On Local Coverage Determinations; Raises Separate Treatment Applications A Patient Can Receive From 4 To 8; Increased Treatment Duration From 12 To 16 Weeks

MiMedx集團提供有關地方覆蓋決定的更新；將患者可以接受的單獨治療申請從4個增加到8個；將治療持續時間從12周延長到16周。

Benzinga · 11/14 22:17

The number of separate treatment applications a patient can receive was raised from 4 to 8
Treatment duration increased from 12 to 16 weeks
- Importantly, the MACs have maintained their insistence on well-powered, peer-reviewed clinical evidence as a prerequisite for reimbursement.

患者可接受的單獨治療申請數量從4增加到8
治療持續時間從12增加到16周
- 重要的是，MACs仍堅持要求有充分力量、經過同行評審的臨床證據作爲報銷的先決條件。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。